Beijing Shougang Langze FY26 H1 net loss narrows 30.1% to RMB 118.12 million; revenue rises 9.9% to RMB 292.53 million

• Beijing Shougang Langze posted a six-month net loss of RMB 118.12 million, narrowing 30.1% year over year.
• Revenue rose 9.9% to RMB 292.53 million, driven by ethanol revenue of RMB 240.54 million and microbial protein revenue of RMB 49.36 million.
• Gross loss narrowed 63.9% to RMB 19.99 million; gross loss margin improved 14 percentage points to 6.8%.
• EBITDA loss (non-IFRS) narrowed to RMB 37.74 million; adjusted EBITDA loss (non-IFRS) improved to RMB 18.79 million.
• Hebei Shoulang Phase II facility began trial production in June 2026; SAF project targets contract signing around Q3 2026, construction readiness around Q1 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beijing Shougang Langze Technology Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260827-12301607), on August 27, 2026, and is solely responsible for the information contained therein.